Rate of maxillary molar intrusion for correction of anterior open bite · Adolescents and adults with malocclusion undergoing fixed orthodontic appliance treatment
1 finding from 1 review
Two studies (62 participants), not pooled. Abellan 2021: no significant difference in molar intrusion at 3 months (1.25 vs 1.72 mm) or 6 months (1.09 vs 1.28 mm), nor rate per month. Hasan 2022: increased intrusion…
2 studies · 62 participants
GRADE not reported
MMP-8 location/presence · Human carious dentin
Evidence on MMP-8 by lesion depth or location was very low certainty.
1 finding from 1 review
Orthodontically-induced inflammatory root resorption (OIIRR) during molar intrusion · Adolescents and adults with malocclusion undergoing fixed orthodontic appliance treatment
1 finding from 1 review
Dental caries · School children in Dubai governmental schools
Mean DMFT was 2.66 in low socioeconomic-class schools versus 2.10 in high-class schools.
1 finding from 1 review
Poor oral health-related quality of life (OHRQoL) · Children aged 3-12 years
Children from low-income families had higher odds of poor OHRQoL (OR 1.16, 95% CI 1.11-1.21; 4 studies; ungraded).
1 finding from 1 review
OR 1.16 [1.11, 1.21]
4 studies
GRADE not reported
Death or bronchopulmonary dysplasia at 36 weeks PMA · health problem or population
It is very uncertain whether summary of Findings Table ‐ Low changes death or BPD at 36 weeks PMA compared with moderate‐high nasal continuous positive airway pressure levels (very low certainty).
1 finding from 1 review
BPD at 28 days · health problem or population
The review found no eligible studies for this question.
2 findings from 1 review
BPD (36 weeks' PMA) · health problem or population
It is very uncertain whether summary of Findings Table ‐ Low changes BPD, defined as supplemental oxygen or positive pressure support use… compared with moderate‐high nasal continuous positive airway pressure levels (very low certainty).
1 finding from 1 review
Treatment failure or need for mechanical ventilation · health problem or population
It is very uncertain whether summary of Findings Table ‐ Low changes treatment failure or need for mechanical ventilation compared with moderate‐high nasal continuous positive airway pressure levels (very low certainty).
2 findings from 1 review
Mortality before hospital discharge · health problem or population
It is very uncertain whether summary of Findings Table ‐ Low changes mortality, by hospital discharge compared with moderate‐high nasal continuous positive airway pressure levels (very low certainty).
2 findings from 1 review
Moderate‐severe neurodevelopmental impairment at 18 to 26 months ‐ not measured · health problem or population
The review found no eligible studies for this question.
2 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
Bronchopulmonary dysplasia/chronic lung disease · health problem or population
It is very uncertain whether summary of Findings Table ‐ Low changes BPD, defined as supplemental oxygen or positive pressure support use… compared with moderate‐high nasal continuous positive airway pressure levels (very low certainty).
1 finding from 1 review
Combined outcome of mortality or BPD at 36 weeks' PMA · health problem or population
It is very uncertain whether summary of Findings Table ‐ Low changes death or BPD at 36 weeks' PMA compared with moderate‐high nasal continuous positive airway pressure levels (very low certainty).
1 finding from 1 review
Observed number of pregnancies (all women) · women seeking emergency contraception
Low‐dose mifepristone (< 25 mg) leads to lower observed number of pregnancies (all women) compared with levonorgestrel 1.5 mg (high certainty).
1 finding from 1 review
Side effects · women seeking emergency contraception
Low‐dose mifepristone (< 25 mg) may leads to lower any side effect compared with levonorgestrel 1.5 mg (low certainty).
1 finding from 1 review
Nausea · women seeking emergency contraception
Low‐dose mifepristone (< 25 mg) showed no clear difference in specific side effect ‐ nausea compared with levonorgestrel 1.5 mg (moderate certainty).
1 finding from 1 review
Vomiting · women seeking emergency contraception
Low‐dose mifepristone (< 25 mg) showed no clear difference in specific side effect ‐ vomiting compared with levonorgestrel 1.5 mg (low certainty).
1 finding from 1 review
Specific side effects ‐ spotting/bleeding after treatment · women seeking emergency contraception
Low‐dose mifepristone (< 25 mg) leads to lower specific side effect ‐ spotting/bleeding after treatment compared with levonorgestrel 1.5 mg (high certainty).
1 finding from 1 review
Menses ‐ early · women seeking emergency contraception
Low‐dose mifepristone (< 25 mg) may leads to lower menses ‐ early compared with levonorgestrel 1.5 mg (low certainty).
1 finding from 1 review
Menses ‐ delay · women seeking emergency contraception
Low‐dose mifepristone (< 25 mg) may leads to higher menses ‐ delay compared with levonorgestrel 1.5 mg (low certainty).
1 finding from 1 review